Australia and New Zealand Sarcoma Association
@anzsarcoma
Followers
754
Following
620
Media
443
Statuses
722
The Australia and New Zealand Sarcoma Association is the peak body for the sarcoma community. ANZSA is formerly known as ASG and ASSG.
Melbourne, Victoria
Joined November 2016
Welcome to our newly appointed ANZSA Board Directors! A/Prof Richard Boyle (RPA Hospital) & Andy Johnston (Auckland City Hospital) bring world-class expertise in sarcoma care, orthopaedics & research to guide ANZSA’s mission.
0
0
2
Final day of #ANZSAASM2025 in Hobart wrapped with big energy—AI in sarcoma care, patient-reported outcomes, palliative integration, AYA needs, lived experience and the Great Debate on regional vs centre-based care. Congrats to Barnaby Kelly on best poster!
0
1
2
Kicking off #ANZSAASM2025 with a warm welcome from Fiona Maclean and opening remarks by Tasmanian Senator Wendy Askew. Our wonderful Consumer Advisor, Natalia Dewiyani, shared plenty of hugs and delivered a beautiful opening speech.
0
1
3
We’ve arrived in Hobart! To kick things off, the ANZSA Scientific Advisory Committee is meeting to discuss recent research developments and explore future directions. It’s wonderful to see sarcoma specialists and consumers from across Australia and New Zealand collaborating.
0
2
3
ASM is so close! One of the most anticipated speakers is Prof Jason Yustein, pediatric oncologist and physician-scientist from Children’s Healthcare of Atlanta. To download the program, visit: https://t.co/Ii5DbE7mnn Attend online or in person visit: https://t.co/Au7WrFEOXY
0
0
0
Thank you to our Board Director, Dr @VivekBhadri and our Scientific Advisor, A/Prof Jeremy Lewin for contributing their expertise to our 2025 Sarcoma Awareness Month campaign through their interview with Australian Health Journal.
MISSION TO RAISE AWARENESS OF SARCOMA AND CLINICAL TRIAL FUNDING Research lagging for sarcoma, despite accounting for one third of adolescent cancer deaths With Associate Professor Jeremy Lewin, Medical Oncologist, Peter MacCallum Cancer Centre & Medical Director, Victorian
0
2
3
🚨 Our ASM is only a few months away! We will gather in Hobart to share expertise, foster collaboration, and drive innovation in sarcoma care and research. 2025 Theme: "United Against Sarcoma: Collaboration and Innovation." Register today: https://t.co/tVVPVjT8AV
0
3
6
Abstract submissions due tomorrow by MIDNIGHT (AEST)! Join us under the theme Collaboration & Innovation. Kudos to 2024 Poster Prize winner Jacqui McGovern for her inspiring work—your poster could be next. Submit here: https://t.co/LjsB9ifXRW
0
0
0
📢 1 Week Left to Submit Your Abstract There’s just 1 week remaining to submit your abstract for the 2025 ASM. Abstract/poster submissions must be received electronically via the online form by midnight (AEST) on Friday 1 August 2025. Submit: https://t.co/P1dspirmbU
0
2
2
Today our wonderful Deputy Chair, Professor @AngelaHong, lead her GenesisCare Plank-a-thon team in Sydney for sarcoma research! To sign up or show your support, please visit https://t.co/YjsSJLBjeX
#sarcomaawareness #research #teamspirit
0
2
4
Next Thursday! Join us for our second #sarcomaawarenessmonth Webinar in collaboration with @VCCCAlliance Register here: https://t.co/Xg5fogmDmU
1
6
11
Join us for our first Sarcoma Awareness Month webinar in collaboration with @VCCCAlliance. Register here: https://t.co/WdVDgKOwtI
0
3
3
Calling all researchers. Showcase your work at the 2025 ANZSA ASM and help shape the future of sarcoma care. Share your findings with a multidisciplinary audience committed to innovation. Abstract submissions are now open- Don't miss out! Submit here: https://t.co/LjsB9ifXRW
0
2
5
📢 The Provisional Program for the ANZSA Annual Scientific Meeting is now available. Take a look at the planned sessions and speakers, and don’t forget to register to attend. View the program here: https://t.co/Ii5DbE7mnn
0
1
0
@PeterMacCC has become first site in the world activated for a key stage of INTER-EWING-1 trial, a major global program improving outcomes for Ewing #Sarcoma - opening recruitment to Randomisations B1 and B2 to explore role of radiotherapy survival & recurrence risk😊
1
2
4
Congratulations to Hayden Snow and David Gyorki on the publication of their latest paper in collaboration with the @TARPSWG. A major step forward for improving outcomes for retroperitoneal sarcoma through international collaboration. Read here:
journals.lww.com
ospectively collected within the RESAR repository (NCT03838718) between Feb 2017 – July 2022. Centres were categorised high volume (HVC) or low volume (LVC). Comprehensive resection (CR) was defined...
0
4
4
We’re pleased to announce that @WinshipAtEmory in the US, is the second international site to join the ReLaPSe study - a prospective study evaluating standard treatment options for patients who’ve had a recurrence of a resected #retroperitoneal #liposarcoma.
1
3
10
Abstract submissions are now open for the 2025 ANZSA Annual Scientific Meeting. We’re inviting poster submissions from all areas of sarcoma research! Deadline: Friday 1 August 2025 (midnight AEST) 📎 Follow the submission instructions at: https://t.co/P1dspiqOmm
0
4
3
Join leading minds in sarcoma research and care at the 2025 ANZSA Annual Scientific Meeting, October 10–11 in Hobart. Connect with clinicians, researchers, and advocates to explore the latest in sarcoma science and multidisciplinary care. Register today: https://t.co/Au7WrFEOXY
0
2
1
EP300::VGLL3 #rhabdomyosarcoma: a potential distinct indolent adult RMS subtype 🚨Think of this emerging subtype if: ✔️Male, aged 30-60 ✔️ Spindle cell / sclerosing #RMS 👅 of the tongue 🙌🏻 Appear indolent with good outcomes in all reported cases https://t.co/7DKkbIA1ez
5
17
33